Processing of HIV-1 envelope glycoprotein for class I-restricted recognition: Dependence on TAP1/2 and mechanisms for cytosolic localization

Journal of Immunology

Volumn 162, Issue 3, 1999, Pages 1324-1332

  Ferris, Robert L ^a,b   Hall, Christopher ^a   Sipsas, Nikolaos V ^c   Safrit, Jeffrey T ^d   Trocha, Alicja ^c   Koup, Richard A ^e,f   Johnson, R Paul ^c   Siliciano, Robert F ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINE; ASPARTIC ACID; CARRIER PROTEIN; CD8 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN;

ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; CYTOSOL; CYTOTOXIC T LYMPHOCYTE; ENDOPLASMIC RETICULUM; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; PROTEIN LOCALIZATION; PROTEIN PROCESSING;

AMINO ACID SEQUENCE; ANTIGEN PRESENTATION; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT, ACTIVE; CELL LINE; CLONE CELLS; CYTOSOL; ENDOPLASMIC RETICULUM; EPITOPES; GENE PRODUCTS, ENV; GENES, ENV; HISTOCOMPATIBILITY ANTIGENS CLASS I; HIV ANTIGENS; HIV ENVELOPE PROTEIN GP120; HIV-1; HLA-C ANTIGENS; HUMANS; MODELS, BIOLOGICAL; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0033082513     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (73)

1. York, I., and K. L. Rock. 1996. Antigen processing and presentation by the class I major histocompatibility complex. Annu. Rev. Immunol. 14:369.
2. Yewdell, J. W., and J. R. Bennink. 1992. Cell biology of antigen processing and presentation to MHC class I molecule-restricted T lymphocytes. Adv. Immunol. 52:1.
3. Germain, R. N. 1994. MHC-dependent antigen processing and peptide presentation:providing ligands for T lymphocyte activation. Cell 76:287.
4. Morrison, L. A., A. Lukacher, V. L. Braciale, D. P. Fan, and T. P. Braciale. 1986. Differences in antigen presentation to MHC class I and class II-restricted influenza virus specific cytolytic T lymphocyte clones. J. Exp. Med. 163:903.
5. Townsend, A., J. A. Rothbard, F. Gotch, D. Bahadur, D. C. Wraithe, and A. McMichael. 1986 The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell 44: 959.
6. Moore, M. W., F. W. Carbone, and M. J. Bevan. 1988. Introduction of soluble antigen into the class I pathway of antigen processing and presentation. Cell 54:777.
7. Trowsdale, J., I. Hanson, I. Mockridge, S. Beck, A. Townsend, and A. Kelly. 1990. Sequences encoded in the class II region of the MHC related to the 'ABC' superfamily of transporters. Nature 348:741.
8. Spies, T., M. Bresnahan, S. Bahrain, D. Arnold, G. Blanck, E. Mellins, D. Pious, and R. DeMars. 1990. A gene in the human major histocompatibility complex class II region controlling the class I antigen presentation pathway. Nature 348: 744.
9. Monaco, J. J., S. Cho, and M. Attaya. 1990. Transport protein genes in the murine MHC:possible implications for antigen processing. Science 250:1723.
10. Powis, S. J., A. R. Townsend, E.V. Deverson, J. Bastin, G. W. Butcher, and J. C. Howard. 1991. Restoration of antigen presentation to the mutant cell line RMA-S by an MHC-linked transporter. Nature 354:528.
11. Spies, T., and R. DeMars. 1991. Restored expression of major histocompatibility class I molecules by gene transfer of a putative peptide transporter. Nature 351: 323.
12. Kelly, A., S. H. Powis, R. Glynne, E. Radley, S. Beck, and J. Trowsdale. 1991. Second proteasome-related gene in the human MHC class II region. Nature 353: 667.
13. Attaya, M., S. Jameson, C. K. Martinez, E. Hermel, C. Aldrich, J. Forman, K. F. Lindahl, M. J. Bevan, and J. J. Monaco. 1992. Ham-2 corrects the class I antigen-processing defect in RMA-S cells. Nature 355:647.
14. Kleijmeer, M. J., A. Kelly, H. J. Geuze, J. W. Slot, A. Townsend, and J. Trowsdale. 1992. Location of MHC-encoded transporters in the endoplasmic reticulum and cis-Golgi. Nature 357:342.
15. + T cells. Cell 71:1205.
16. Shepherd, J. C . T. N. Schumacher, P. G. Ashton-Rickardt, S. Imaeda, H. Ploegh, and C. T. S. Janeway. 1993. TAPI-dependent peptide translocation in vitro is ATP-dependent and peptide selective. Cell 74:577.
17. 2-microglobulin complexes associate with TAP transporters before peptide binding. Nature 368:864.
18. Suh, W.-K., M. Cohen-Doyle, K. Fruh, K. Wang, P. A. Peterson, and D. Williams. 1994. Interaction of MHC class I molecules with the transporter associated with antigen processing. Science 264:1322.
19. Lehner, P. J., M. J. Surman, and P. Cresswell. 1998. Soluble tapasin restores MHC class I expression and function in the tapasin-negative cell line. 220. Immunity 8:221.
20. Kulig, K., D. Nandi, I. Bacik, J. J. Monaco, and S. Vukmanovic. 1998. Physical and functional association of the major histocompatibility complex class I heavy chain α 3 domain with the transporter associated with antigen processing. J. Exp. Med. 187:865.
21. Siliciano, R. F., and M. J. Soloski. 1995. MHC class I-restricted processing of transmembrane proteins:mechanism and biologic significance. J. Immunol. 155:2.
22. Ward, C., S. Omura, and R. Kopito. 1995. Degradation of CFTR by the ubiquitin-proteasome pathway. Cell 83:121.
23. Wiertz, E. J., T. R. Jones, L. Sun, M. Bogyo, H. J. Geuze, and H. L. Ploegh. 1996. The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell 84:769.
24. Wiertz, E. J., D. Tortorella, M. Bogyo, J. Yu, W. Mothes, T. R. Jones, T. A. Rapoport, and H. L. Ploegh. 1996. SEC61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction. Nature 384:432.
25. Hughes, E. A., C. Hammond, and P. Cresswell. 1997. Misfolded major histocompatibility complex class I heavy chains are translocated into the cytoplasm and degraded by the proteasome. Proc. Natl. Acad. Sci. USA 94:1896.
26. McCracken, A. A., and J. Brodsky. 1996. Assembly of ER-associated protein degradation in vitro:dependence of cytosol, calnexin, and ATP. J. Cell Biol. 132:291.
27. Pilon, M., R. Schekman, and K. Romisch. 1997. Sec61p mediates export of misfolded secretory protein from the endoplasmic reticulum to the cytosol for degradation. EMBO J. 16:4540.
28. Plemper, R. K., S. Bohmler, J. Bordallo, T. Sommer, and D. H. Wolf. 1997. Mutant analysis links the translocon and BiP to retrograde protein transport for ER degradation. Nature 388:891.
29. Werner, E. D., J. Brodsky, and A. A. McCracken. 1996. Proteasome-dependent endoplasmic reticulum-associate protein degradation:and unconventional route to a familiar fate. Proc. Natl. Acad. Sci. USA 93:13797.
30. Hiller, M. M., A. Finger, M. Schweiger, and D. H. Wolf. 1996. ER degradation of a misfolded lumenal protein by the cytosolic ubiquitin-proteasome pathway. Science 273:1725.
31. Biederer, T. C., C. Volkwein, and T. Sommer. 1996. Degradation of subunits of the Sec61p complex, an integral component of the ER membrane, by the ubiquitin-proteasome pathway. EMBO J. 15:2069.
32. Huppa, J., and H. Ploegh. 1997. The α chain of the T cell antigen receptor is degraded in the cytosol. Immunity 7:113.
33. Yang, M., S. Omura, J. S. Bonifacino, and A. Weissman. 1998. Novel aspects of degradation of T cell receptor subunits from the endoplasmic reticulum (ER) in T cells:importance of oligosaccharide processing, ubiquitination, and proteasome-dependent removal from ER membranes. J. Exp. Med. 187:835.
34. Mosse, C., L. Meadows, C. Luckey, D. J. Kittlesen, E. Huczko, C. L. Slingluff, J. Shabanowitz, D. F. Hunt, and V. H. Engelhard. 1998. The class I antigen-processing pathway for the membrane protein tyrosinase involves translation in the endoplasmic reticulum and processing in the cytosol. J. Exp. Med. 187:37.
35. Skipper, J. C. A., R. C. Hendrickson, P. H. Gulden, V. Brichard, A. Vanpel, Y. Chen, J. Shabanowitz, T. Wolfel, C. L. Slingluff, T. Boon, D. F. Hunt, and V. H. Engelhard. 1996. An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins. J. Exp. Med. 183:527.
36. Bacik, J., H. L. Snyder, L. Anton, G. Russ, W. Chen, J. Bennink, L. Urge, L. Otvos, B. Dudkowska, L. C. Eisenlohr, and J. Yewdell. 1997. Introduction of a glycosylalion site into a secreted protein provides evidence of an alternative antigen processing pathway:transport of precursors of major histocompatibility complex class I-restricted peptides from the endoplasmic reticulum to the cytosol. J. Exp. Med. 186:479.
37. Koup, R. A., J. A. Safrit, Y. Cao, C. A. Andrews, G. McLeod, W. Borkowsky, C. Farthing, and D. D. Ho. 1994. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68:4650.
38. Rinaldo, C., H. Xiao-Li, Z. Fan, M. Ding, L. Beltz, A. Logar, D. Panicalli, G. Mazzara, J. Liebmann, M. Cottrill, and P. Gupta. 1995. High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors. J. Virol. 69:5838.
39. Musey, L., J. Hughes, T. Schacker, T. Shea, L. Corey, and M. J. McElrath. 1997. Cytotoxic T cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection. N. Engl. J. Med. 337:1267.
40. McMichael, A., and R. Phillips. 1997. Escape of human immunodeficiency virus from immune control. Annu. Rev. Immunol. 15:271.
41. + T cells. Nature 364:158.
42. + CTL. J. Immunol. 154:6140.
43. Ferris, R. L., C. Buck, S. A. Hammond, A. S. Woods, R. J. Cotter, M. Takiguchi, Y. Igarashi, Y. Ichikawa, and R. F. Siliciano. 1996. Class I-restricted presentation of an HIV-1 gp41 epitope containing an N-linked glycosylation site:implications for the mechanism of processing of viral envelope proteins. J. Immunol. 156:834.
44. Townsend, A., J. Bastin, K. Gould, G. Brownlee, M. Andrew, B. Coupar, D. Boyle, S. Chan, and G. Smith. 1988. Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen. J. Exp. Med. 168:1211.
45. Tobery, T., and R. F. Siliciano. 1997. Targeting of HIV-1 antigens for rapid intracellular degradation enhances CTL recognition and the induction of de novo CTL responses in vivo following immunization. J. Exp. Med. 185:909.
46. + cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines. J. Exp. Med. 176:1531.
47. Johnson, R. P., S. A. Hammond, A. Trocha, R. F. Siliciano, and B. D. Walker. 1994. Induction of a major histoeompatibility complex class I-restricted cytotoxic T-lymphocyte response to a highly conserved region of human immunodeficiency virus type 1 (HIV-1) gp120 in seronegative humans immunized with a candidate HIV-1 vaccine. J. Virol. 68:3145.
48. Sipsas N. V., S. A. Kalams, A. Trocha, S. He, W. A. Blattner, B. D. Walker, and R. P. Johnson. 1997. Identification of type-specific cytotoxic T lymphocyte responses to homologous viral proteins in laboratory workers accidentally infected with HIV-1. J. Clin. Invest. 99:752.
49. Safrit, J., A. Lee, C. Andrews, and R. Koup. 1994. A region of the third variable loop of HIV gp120 is recognized by HLA B7-restricted CTLs from two acute seroconversion patients. J. Immunol. 153:3822.
50. Johnson, R. P., A. Trocha, T. M. Buchanan, and B. D. Walker, 1992. Identification of overlapping HLA class I-restricted cytotoxic T cell epitopes in a conserved region of the human immunodeficiency virus type 1 envelope glycoprotein:definition of minimum epitopes and analysis of the effects of sequence variation. J. Exp. Med. 175:961.
51. Safrit, J. T., C. A. Andrews, T. Zhu, D. D. Ho, and R. A. Koup. 1994. Characterization of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte clones isolated during acute seroconversion:recognition of autologous virus sequences within a conserved immunodominant epitope. J. Exp. Med. 179:463.
52. Earl, P. L., A. W. Hugin, and B. Moss. 1990. Removal of cryptic poxvirus transcription termination signals from the human immunodeficiency virus type 1 envelope gene enhances expression and immunogenicity of a recombinant vaccinia virus. J. Virol. 64:2448.
53. Banks, T. A., F. J. Jenkins, S. Kanangat, S. Nair, S. Dasgupta, C. M. Foster, and B. T. Rouse. 1994. Vaccination with the immediate-early protein ICP47 of herpes simplex virus-type 1 (HSV-1) induces virus-specific lymphoproliferation, but fails to protect against lethal challenge. Virology 200:236.
54. Fenteany G., R. F. Standaert, W. S. Lane, S. Choi, E. J. Corey, and S. Schreiber. 1995. Inhibition of proteasome activities and summit-specific amino-terminal threonine modification by lactacystin. Science 268:726.
55. Bogyo, M. J. S. McMaster, M. Gaczynska, D. Tortorella, A. L. Goldberg, and H. Ploegh. 1997. Covalent modification of the active site threonine of proteasomal β subunits and the Escherichia coli homolog HsIV by a new class of inhibitors. Proc. Natl. Acad. Sci. USA 94:6629.
56. Bogyo, M., Gaczynska M. and H. Ploegh. 1997. Proteasome inhibitors and antigen presentation. Biopolymers 43:269.
57. Hill, A., P. Jugovic, I. York, G. Russ, J. Bennink, J. Yewdell, H. Ploegh, and D. Johnson. 1995. Herpes simplex virus turns off the TAP to evade host immunity. Nature 375:411.
58. Tomazin, R., A. Hill, P. Jugovic, I. York, P. M. van Endert, H. Ploegh, D. Andrews, and D. Johnson. 1996. Stable binding or the herpes simplex virus ICP47 protein to the peptide binding site of TAP. EMBO J. 15:3256.
59. Ahn, K., T. Meyer, S. Uebel, P. Sempe, H. Djaballah, Y. Yang, P. A. Peterson, K. Fruh, and R. Tampe. 1996. Molecular mechanisms and species specificity of TAP inhibition by herpes simplex virus protein ICP47. EMBO J. 15:3247.
60. Lubaki, M., M. A. Egan, R. F. Siliciano, K. J. Weinhold, and R. C. Bollinger. 1994. A novel method for detection and ex vivo expansion of HIV type 1-specific cytolytic T lymphocytes. AIDS Res. Hum. Retroviruses 10:1423.
61. Leonard, C., M. Spellman, L. Riddle, R. Harris, J. Thomas, and T. Gregory. 1990. Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant immunodeficiency virus envelope glycoproteins (gp120) expressed in Chinese hamster ovary cells. J. Biol. Chem. 265: 10373.
62. Suzuki, T., A. Seko, K. Kitajima, Y. Inoue, and S. Inoue. 1993. Identification of peptide:N-glycanase activity in mammalian-derived culture cells. Biochem. Biophys. Res. Commun. 194:1124.
63. Suzuki, T., A. Seko, K. Kitajima, Y. Inoue, and S. Inoue. 1994. Purification and enzymatic properties of peptide:N-glycanase from C3H mouse derived L-929 fibroblast cells. J. Biol. Chem. 269:17611.
64. Suzuki, T., K. Kitajima, E. Yasafumi, Y. Inoue, and S. Inoue. 1997. Site-specific de-N-glycosylation of diglycosylated ovalbumin in hen oviduct by endogenous peptide:N-glycanase as a quality control system for newly synthesized proteins. Proc. Natl. Acad. Sci. USA 94-6244.
65. Huczko, E., W. Bodnar, D. Benjamin, K. Sakaguchi, N. Zhu, J. Shabanowitz, R. Henderson, E. Appella, and V. H. Engelhard. 1993. Characteristics of endogenous peptides eluted from the class I MHC molecule HLA-B7 determined by mass spectrometry and computer modeling. J. Immunol. 151:2572.
66. Selby, M., A. Erickson, C. Dong, S. Cooper, P. Parham, M. Houghton, and C. Walker. 1999. Hepatitis C virus envelope glycoprotein E1 originates in the endoplasmic reticulum and requires cytoplasmic processing for presentation by class I MHC molecules. J. Immunol. 162:669.
67. Bischoff, R., and H. Kolbe. 1994. Deamidation of asparagine and glutamine residues in proteins and peptides:structural determinants and analytical methodology. J. Chromatogr. 662:262.
68. Midelfort, C., and A. Mehler. 1972. Deamidation in vivo of an asparagine residue in rabbit skeletal muscle aldolase. Proc. Natl. Acad. Sci. USA 69:1816.
69. Robinson, A., J. McKerrow, and P. Cary. 1970. Controlled deamidation of peptides and proteins:an experimental hazard and a possible biological timer. Proc. Natl. Acad. Sci. USA 66:753.
70. Stewart A., S. Arfin, and R. Bradshaw. 1994. Protein NH2-terminal asparagine deaminase. J. Biol. Chem. 269:23509.
71. Yewdell, J., and J. Bennink. 1996. Defective ribosomal products (DRiPs):a major source of antigenic peptides for MHC class I molecules? J. Immunol. 157: 1823.
72. Bullock. T., and L. C. Eisenlohr. 1996. Ribosomal scanning past the primary initiation codon as a mechanism for expression of CTL epitopes encoded in alternate reading frames. J. Exp. Med. 184:1319.
73. Hegde, R., S. Voigt, T. A. Rapoport, and V. Lingappa. 1998. TRAM regulates the exposure of nascent secretory proteins to the cytosol during translocation into the endoplasmic reticulum. Cell 92:621.